OverviewChartProfileKey statisticsFinancialsNewsTraderScreen

Advanced Micro Devices/  US0079031078  /

Cboe US
5/31/2024  9:59:59 PM Chg. +0.40 Volume Bid1:51:18 AM Ask1:56:14 AM Market Capitalization Dividend Y. P/E Ratio
167.13USD +0.24% 1.85 mill.
Turnover: 208.3 mill.		 162.50Bid Size: 1 168.00Ask Size: 26 269.76 bill.USD - 314.91
GlobeNewswire 5/31 Data and Safety Monitoring Board Approves Simultaneous Enrollment in Cohort 3 and Phase 2 Initiation...
GlobeNewswire 5/29 GRANITESHARES SURPASSES $5B AUM AS TRADING VOLUMES SURGE
GlobeNewswire 5/29 Alkeus Pharmaceuticals Appoints Eric L. Trachtenberg as Chief Legal Officer
GlobeNewswire 5/28 AMD Chair and Chief Executive Officer Dr. Lisa Su to Deliver the Opening Keynote at Computex 2024
GlobeNewswire 5/28 Outlook Therapeutics® Receives European Commission Marketing Authorization for LYTENAVA™ (bevacizuma...
GlobeNewswire 5/28 Opthea Completes Enrollment in Pivotal Phase 3 Clinical Program with Sozinibercept in Wet AMD
GlobeNewswire 5/21 AMD Instinct MI300X Accelerators Power Microsoft Azure OpenAI Service Workloads and New Azure ND MI3...
GlobeNewswire 5/21 AMD Expands EPYC CPU Portfolio to Bring New Levels of Performance and Value for Small and Medium Bus...
GlobeNewswire 5/21 Clearside Biomedical Announces Publication of Consensus Guidelines for Drug Delivery via Suprachoroi...
GlobeNewswire 5/21 YieldMax™ Launches Option Income Strategy ETF on the VanEck® Gold Miners ETF (GDX®)
TeleTrader 5/20 Microsoft will 'soon welcome' AMD, Intel chips
GlobeNewswire 5/20 Broadcom Revolutionizes AI Networking Landscape with High-Performance 400G RoCE/RDMA Ethernet NICs
Newsfile Corp 5/16 FDA Grants AI-Powered Notal Vision Home OCT "SCANLY" De Novo Marketing Authorization
GlobeNewswire 5/15 Outlook Therapeutics® Reports Financial Results for Second Quarter Fiscal Year 2024 and Provides Cor...
GlobeNewswire 5/14 AMD Announces Upcoming Events for the Financial Community
GlobeNewswire 5/14 Apellis Pharmaceuticals Refinances Existing Debt with Up to $475 Million Non-Dilutive Credit Facilit...
GlobeNewswire 5/14 Belite Bio to Participate in the Benchmark’s 4th Annual Healthcare House Call Investor Conference
GlobeNewswire 5/14 Belite Bio Reports First-Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire 5/13 Outlook Therapeutics® Announces UK Submission of Marketing Authorization Application (MAA) for ONS-5...
GlobeNewswire 5/13 AMD Remains the Partner of Choice for World’s Fastest and Most Efficient High Performance Computing ...
GlobeNewswire 5/9 Clearside Biomedical Announces First Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire 5/9 Adverum Biotechnologies Reports First Quarter 2024 Financial Results and Provides Pipeline Highlight...
GlobeNewswire 5/9 4DMT Reports First Quarter 2024 Financial Results and Operational Highlights
GlobeNewswire 5/8 Alkeus Pharmaceuticals Announces Positive Interim Results Demonstrating No Signs of Disease Progress...
GlobeNewswire 5/8 Therini Bio Announces Positive Preclinical Data Supporting the Development of THN391 in Neurodegener...